GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
Saved in:
EINFELD, S.L., GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES. AUSTRALIA AND NEW ZEALAND JOURNAL OF DEVELOPMENTAL DISABILITIES, Vol. 16, no. 1 (1990), p. 71-73.
Ref.
20149
Sted:
SIIS R.117 Depósito (8/9)
Palabras clave:
Conducta, Discapacidad, Fármacos, Psicótropos, Recomendaciones, Terapia
Conducta, Discapacidad, Fármacos, Psicótropos, Recomendaciones, Terapia
Lignende værker: GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- GUIDELINES FOR THE USE OF CLOZAPINE IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- PSYCHOTROPIC MEDICATION USE FOR CHALLENGING BEHAVIORS IN PERSONS WITH INTELLECTUAL DISABILITIES: AN OVERVIEW
- THE USE OF PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES LIVING IN CANADA
- RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE
- A CONSUMER'S GUIDE TO MONITORING PSYCHOTROPIC MEDICATION FOR INDIVIDUALS WITH AUTISM SPECTRUM DISORDERS
- MENTAL ILLNESS AND PSYCHOTROPIC MEDICATION USE IN THE NURSING HOME